Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

1.

[Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases].

Lipsker D, Lenormand C.

Ann Dermatol Venereol. 2012 Jun;139(6-7):459-67. doi: 10.1016/j.annder.2012.03.012. Epub 2012 Apr 17. Review. French.

PMID:
22721478
[PubMed - indexed for MEDLINE]
2.

Neutrophilic dermatoses: a review of current treatment options.

Cohen PR.

Am J Clin Dermatol. 2009;10(5):301-12. doi: 10.2165/11310730-000000000-00000. Review.

PMID:
19658442
[PubMed - indexed for MEDLINE]
3.

An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.

Pazyar N, Feily A, Yaghoobi R.

Curr Clin Pharmacol. 2012 Nov;7(4):271-5. Review.

PMID:
22794157
[PubMed - indexed for MEDLINE]
4.

MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.

Wittkowski H, Kuemmerle-Deschner JB, Austermann J, Holzinger D, Goldbach-Mansky R, Gramlich K, Lohse P, Jung T, Roth J, Benseler SM, Foell D.

Ann Rheum Dis. 2011 Dec;70(12):2075-81. doi: 10.1136/ard.2011.152496. Epub 2011 Sep 8.

PMID:
21908452
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.

Kalliolias GD, Liossis SN.

Expert Opin Investig Drugs. 2008 Mar;17(3):349-59. doi: 10.1517/13543784.17.3.349 . Review.

PMID:
18321234
[PubMed - indexed for MEDLINE]
6.

[IL-1 antagonists].

Kötter I, Horneff G.

Z Rheumatol. 2010 Sep;69(7):581-93. doi: 10.1007/s00393-009-0530-7. German.

PMID:
20703489
[PubMed - indexed for MEDLINE]
7.

Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.

Yu JR, Leslie KS.

Curr Allergy Asthma Rep. 2011 Feb;11(1):12-20. doi: 10.1007/s11882-010-0160-9.

PMID:
21104172
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.

Guignard S, Dien G, Dougados M.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):758-9.

PMID:
18078628
[PubMed - indexed for MEDLINE]
9.

Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.

Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, Günaydin I, Kanz L.

Semin Arthritis Rheum. 2007 Dec;37(3):189-97. Epub 2007 Jun 20. Review.

PMID:
17583775
[PubMed - indexed for MEDLINE]
10.

Rilonacept in the treatment of chronic inflammatory disorders.

McDermott MF.

Drugs Today (Barc). 2009 Jun;45(6):423-30. doi: 10.1358/dot.2009.45.6.1378935. Review.

PMID:
19649332
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study.

Krause K, Weller K, Stefaniak R, Wittkowski H, Altrichter S, Siebenhaar F, Zuberbier T, Maurer M.

Allergy. 2012 Jul;67(7):943-50. doi: 10.1111/j.1398-9995.2012.02843.x. Epub 2012 May 15.

PMID:
22583335
[PubMed - indexed for MEDLINE]
12.

[CAPS treatment].

Jiménez Treviño S, Ramos Polo E.

Med Clin (Barc). 2011 Jan;136 Suppl 1:29-33. doi: 10.1016/S0025-7753(11)70006-9. Review. Spanish.

PMID:
21596184
[PubMed - indexed for MEDLINE]
13.

A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.

Perdan-Pirkmajer K, Praprotnik S, Tomšič M.

Clin Rheumatol. 2010 Dec;29(12):1465-7. doi: 10.1007/s10067-010-1553-9. Epub 2010 Aug 24. Review.

PMID:
20734215
[PubMed - indexed for MEDLINE]
14.

Treating inflammation by blocking interleukin-1 in humans.

Dinarello CA, van der Meer JW.

Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23. Review.

PMID:
24275598
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Petryna O, Cush JJ, Efthimiou P.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7. No abstract available.

PMID:
22679302
[PubMed - indexed for MEDLINE]
16.

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, Pinto G, Pagnier A, Bodemer C, Bodaghi B, Tardieu M, Prieur AM, Quartier P.

Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.

PMID:
20039428
[PubMed - indexed for MEDLINE]
Free Article
17.

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens.

Kuemmerle-Deschner JB, Wittkowski H, Tyrrell PN, Koetter I, Lohse P, Ummenhofer K, Reess F, Hansmann S, Koitschev A, Deuter C, Bialkowski A, Foell D, Benseler SM.

Arthritis Res Ther. 2013;15(3):R64.

PMID:
23718630
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful.

Perrin F, Néel A, Graveleau J, Ruellan AL, Masseau A, Hamidou M.

Presse Med. 2014 Mar;43(3):319-21. doi: 10.1016/j.lpm.2013.06.028. Epub 2014 Jan 20. No abstract available.

PMID:
24456697
[PubMed - indexed for MEDLINE]
19.

[Anakinra in refractory adult onset Still's disease].

Vercoutere W, Starmans-Kool M, Peeters RM.

Ned Tijdschr Geneeskd. 2011;155(18):A2966. Dutch.

PMID:
21466723
[PubMed - indexed for MEDLINE]
20.

Neutrophilic urticarial dermatosis (NUD) in probable adult-onset Still disease responding to anakinra.

Hartig I, Schroeder JO, Mrowietz U.

J Clin Rheumatol. 2014 Mar;20(2):96-8. doi: 10.1097/RHU.0000000000000078.

PMID:
24561414
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk